From Foreign Policy · Lucas L. Fluegel · · 1m 50s
The West Needs a Pax Biologica
China's biomanufacturing surge threatens U.S. industrial dominance without immediate policy shifts.
In brief
China's biomanufacturing surge threatens U.S. industrial dominance without immediate policy shifts. China is displacing Western firms in biomanufacturing, risking U.S. supply-chain independence without coordinated international action. Originally reported by Foreign Policy.
The West Needs a Pax Biologica
Chinese firms are displacing Western competitors in one of the century’s most important and most overlooked industries.
U.S. Manufacturing Misstep
Every U.S. politician wants to reinvigorate manufacturing, but most are chasing a 2.0-century version of it.
Biomanufacturing Defined
Biomanufacturing uses biological systems to make goods, from beer to mRNA vaccines.
China’s Industrial Leap
China has positioned itself to leapfrog the U.S. in biomanufacturing through state-directed investment.
Glufosinate Case Study
Chinese firms captured 75% price drop in glufosinate herbicide market by shifting from chemical to biological production.
U.S. Policy Fragmentation
U.S. has fragmented industrial policy with $1 billion Pentagon investment versus China’s $4 billion in 2024.
Global Supply Chain Risks
U.S. firms rely on German equipment, Japanese consumables, and South Korean/Swiss production capacity.
Pax Silica Precedent
U.S. launched Pax Silica initiative with $250 million fund and trade coordination for AI supply chains.
Pax Biologica Proposal
A Pax Biologica initiative could unite Germany, Switzerland, Japan, South Korea, UK, and EU for biomanufacturing.
Regulatory Fragmentation
Global regulatory differences delay biomanufacturing scaling by years and increase financial burdens.
China’s Strategic Move
China explicitly frames biomanufacturing standards as securing its global economic competitiveness.
U.S. Regulatory Gaps
U.S. lacks harmonized standards for biomanufacturing, hindering international scaling of products.
Critical Next Step
Harmonizing global biomanufacturing standards is essential for Western supply chain resilience.
U.S. Industrial Risk
Without coordinated action, U.S. will cede biomanufacturing leadership to China.
At a glance
China is displacing Western firms in biomanufacturing, risking U.S. supply-chain independence without coordinated international action.
